In summary, these results reveal that the oncogenic function of L3MBTL2 in pancreatic cancer is closely related to its negative regulatory effect on CGA, which plays a tumor suppressor role in PDAC. The gene discussed is L3MBTL2; the disease is familial pancreatic carcinoma.